MEA Oligonucleotide Synthesis Market: Country-wise Analysis (2024-2032)

Growing genomic research initiatives and expanding molecular diagnostics shaped the regional landscape in ***, with South Africa recording USD *** million, the GCC valued at USD ***.*** million, and the Rest of Middle East & Africa registering USD *** million. In ***, demand is estimated to strengthen as biotechnology companies and healthcare institutions invest in high-precision synthesis platforms to support therapeutic development, infectious disease studies, and personalised medicine. The MEA Oligonucleotide Synthesis Market now reflects deeper collaboration among research centres, CROs, and clinical laboratories seeking scalable and accurate sequencing inputs. From *** to ***, the Oligonucleotide Synthesis market is projected to advance consistently as regional governments emphasise genomic readiness and the pharmaceutical sector adopts advanced oligonucleotide-based workflows. GCC countries are anticipated to achieve USD ***.*** Million by ***, supported by strong R&D funding,...